REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
11.21
+0.04 (0.36%)
Nov 7, 2025, 4:00 PM EST - Market closed
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $567.48 million as of November 7, 2025. Its market cap has increased by 17.88% in one year.
Market Cap
567.48M
Enterprise Value
533.58M
1-Year Change
17.88%
Ranking
Category
Stock Price
$11.21
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $567.48M, a decrease of -24.26%. That is a compound annual growth rate of -2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 567.50M | 48.17% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 821.07B |
| Johnson & Johnson | 449.98B |
| AbbVie | 387.71B |
| UnitedHealth Group | 289.78B |
| AstraZeneca | 263.38B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 218.99B |
| Thermo Fisher Scientific | 213.71B |